Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News WuXi to build new $60m clinical and manufacturing plant WuXi Biologics has pledged to invest $60 million into a new US-based site to expand its clinical and manufacturing arm.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
